In KRAS-mutant pancreatic ductal adenocarcinoma, concurrent inhibition of WEE1 and ERK demonstrated enhanced tumor growth suppression and apoptosis compared to WEE1 inhibition alone [27]. Here, WEE1 is linked to pancreatic ductal adenocarcinoma.